Episurf Medical provides COVID-19 related update ahead of investor conference
Episurf Medical (Nasdaq: EPISB) today provides updates regarding the business activity during Q1 2021, reflecting impacts from the current pandemic. When it issued its Q4 2020 report, published on February 19[th], the company indicated low business volumes resulting from pandemic-related restrictions. However, the company can now report that it is experiencing double-digit growth in gross order intake in Q1 2021 compared to Q1 2020. Furthermore, the company has seen a 45% increase in the number of active customers during the quarter. “These are challenging times, of course, but we are